Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

321 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
A distinct expression of various gene subsets in CD34+ cells from patients with early and advanced myelodysplastic syndrome.
Vasikova A, Belickova M, Budinska E, Cermak J. Vasikova A, et al. Among authors: cermak j. Leuk Res. 2010 Dec;34(12):1566-72. doi: 10.1016/j.leukres.2010.02.021. Epub 2010 Mar 29. Leuk Res. 2010. PMID: 20303173
Incidence of nucleoli in erythroblasts in patients suffering from refractory anemia of myelodysplastic syndrome.
Smetana K, Jirásková I, Cermák J. Smetana K, et al. Among authors: cermak j. Eur J Haematol. 1999 Nov;63(5):332-6. doi: 10.1111/j.1600-0609.1999.tb01136.x. Eur J Haematol. 1999. PMID: 10580565
Validation of WHO classification-based Prognostic Scoring System (WPSS) for myelodysplastic syndromes and comparison with the revised International Prognostic Scoring System (IPSS-R). A study of the International Working Group for Prognosis in Myelodysplasia (IWG-PM).
Della Porta MG, Tuechler H, Malcovati L, Schanz J, Sanz G, Garcia-Manero G, Solé F, Bennett JM, Bowen D, Fenaux P, Dreyfus F, Kantarjian H, Kuendgen A, Levis A, Cermak J, Fonatsch C, Le Beau MM, Slovak ML, Krieger O, Luebbert M, Maciejewski J, Magalhaes SM, Miyazaki Y, Pfeilstöcker M, Sekeres MA, Sperr WR, Stauder R, Tauro S, Valent P, Vallespi T, van de Loosdrecht AA, Germing U, Haase D, Greenberg PL, Cazzola M. Della Porta MG, et al. Among authors: cermak j. Leukemia. 2015 Jul;29(7):1502-13. doi: 10.1038/leu.2015.55. Epub 2015 Feb 27. Leukemia. 2015. PMID: 25721895
Real-time PCR quantification of major Wilms' tumor gene 1 (WT1) isoforms in acute myeloid leukemia, their characteristic expression patterns and possible functional consequences.
Kramarzova K, Stuchly J, Willasch A, Gruhn B, Schwarz J, Cermak J, Machova-Polakova K, Fuchs O, Stary J, Trka J, Boublikova L. Kramarzova K, et al. Among authors: cermak j. Leukemia. 2012 Sep;26(9):2086-95. doi: 10.1038/leu.2012.76. Epub 2012 Mar 20. Leukemia. 2012. PMID: 22430637
5-azacitidine in aggressive myelodysplastic syndromes regulates chromatin structure at PU.1 gene and cell differentiation capacity.
Curik N, Burda P, Vargova K, Pospisil V, Belickova M, Vlckova P, Savvulidi F, Necas E, Hajkova H, Haskovec C, Cermak J, Krivjanska M, Trneny M, Laslo P, Jonasova A, Stopka T. Curik N, et al. Among authors: cermak j. Leukemia. 2012 Aug;26(8):1804-11. doi: 10.1038/leu.2012.47. Epub 2012 Feb 20. Leukemia. 2012. PMID: 22343522
Low-dose cytosine arabinoside (LD-AraC) vs LD-AraC plus granulocyte/macrophage colony stimulating factor vs LD-AraC plus Interleukin-3 for myelodysplastic syndrome patients with a high risk of developing acute leukemia: final results of a randomized phase III study (06903) of the EORTC Leukemia Cooperative Group.
Zwierzina H, Suciu S, Loeffler-Ragg J, Neuwirtova R, Fenaux P, Beksac M, Harousseau J, Nuessler V, Cermak J, Solbu G, Willemze R, de Witte T, Amadori S; EORTC Leukemia Cooperative Group. Zwierzina H, et al. Among authors: cermak j. Leukemia. 2005 Nov;19(11):1929-33. doi: 10.1038/sj.leu.2403934. Leukemia. 2005. PMID: 16151466 Clinical Trial.
Survival, prognostic factors and rates of leukemic transformation in 381 untreated patients with MDS and del(5q): a multicenter study.
Germing U, Lauseker M, Hildebrandt B, Symeonidis A, Cermak J, Fenaux P, Kelaidi C, Pfeilstöcker M, Nösslinger T, Sekeres M, Maciejewski J, Haase D, Schanz J, Seymour J, Kenealy M, Weide R, Lübbert M, Platzbecker U, Valent P, Götze K, Stauder R, Blum S, Kreuzer KA, Schlenk R, Ganser A, Hofmann WK, Aul C, Krieger O, Kündgen A, Haas R, Hasford J, Giagounidis A. Germing U, et al. Among authors: cermak j. Leukemia. 2012 Jun;26(6):1286-92. doi: 10.1038/leu.2011.391. Epub 2012 Jan 13. Leukemia. 2012. PMID: 22289990
[Cell clonality in myelodysplastic syndrome].
Krejcová H, Neuwirtová R, Cermák J, Belicková M, Brdicka R. Krejcová H, et al. Among authors: cermak j. Sb Lek. 2002;103(3):339-48. Sb Lek. 2002. PMID: 12688178 Czech.
Nucleoli in cells of the granulopoietic proliferating compartment in patients suffering from the refractory anemia of the myelodysplastic syndrome.
Smetana K, Jirásková, Cermák J. Smetana K, et al. Among authors: cermak j. Neoplasma. 2000;47(5):280-2. Neoplasma. 2000. PMID: 11130243
Differing clinical features between Japanese and Caucasian patients with myelodysplastic syndromes: Analysis from the International Working Group for Prognosis of MDS.
Miyazaki Y, Tuechler H, Sanz G, Schanz J, Garcia-Manero G, Solé F, Bennett JM, Bowen D, Fenaux P, Dreyfus F, Kantarjian H, Kuendgen A, Malcovati L, Cazzola M, Cermak J, Fonatsch C, Le Beau MM, Slovak ML, Santini V, Lübbert M, Maciejewski J, Machherndl-Spandl S, Magalhaes SMM, Pfeilstöcker M, Sekeres MA, Sperr WR, Stauder R, Tauro S, Valent P, Vallespi T, van de Loosdrecht AA, Germing U, Haase D, Greenberg PL. Miyazaki Y, et al. Among authors: cermak j. Leuk Res. 2018 Oct;73:51-57. doi: 10.1016/j.leukres.2018.08.022. Epub 2018 Sep 6. Leuk Res. 2018. PMID: 30219650 Clinical Trial.
321 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback